Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia

Objectives: To perform a pharmacokinetic/pharmacodynamic (PK/PD) analysis of continuous-infusion (CI) fosfomycin combined with extended-infusion (EI) cefiderocol or CI ceftazidime-avibactam in a case series of severe difficult-to-treat Pseudomonas aeruginosa (DTR-PA) infections. Methods: A single-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Giannella, Maddalena, Rinaldi, Matteo, Gaibani, Paolo, Viale, Pierluigi, Pea, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774893/
https://www.ncbi.nlm.nih.gov/pubmed/36551398
http://dx.doi.org/10.3390/antibiotics11121739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774893/
https://www.ncbi.nlm.nih.gov/pubmed/36551398
http://dx.doi.org/10.3390/antibiotics11121739

Ejemplares similares